Washington University School of Medicine researchers presented a study linking obesity to an increase in the progression ...

Results showed that people with obesity had blood biomarkers for Alzheimer’s that rose more rapidly, including: Tau proteins, ...

The World Health Organization (WHO) released its first-ever guideline on using GLP-1 medications to treat obesity.

Scientists conducted the first study evaluating the impact of obesity on Alzheimer’s disease blood biomarkers. The post New ...

Type 2 diabetes is a disease that involves your blood glucose (also known as blood sugar) being too high, and obesity is a major risk factor that can make you more likely to develop it. “Insulin ...

Researchers have conducted the first study evaluating the impact of obesity on Alzheimer's disease blood biomarkers (BBMs).

Ozempic-style medications have been endorsed as long-term treatments for obesity under new guidelines released by the World ...

December 2, 2025 - To address the growing global health challenge of obesity, which affects more than 1 billion people, the World Health Organization (WHO) has released its first guideline on the use ...

The Obesity Working Group of the Spanish Society of Endocrinology and Nutrition (GOSEEN) conducts various awareness campaigns to address the growing global and national health challenges of obesity.

Is obesity a disease or a risk factor for disease? In medical circles – and outside of them – the question is contentious, with supporters on either side. In a newly published report, the Global ...

“The American public is highly aware that obesity is medically treatable and that reducing it will also save people from a ...

A recent study revealed that obesity may accelerate the progression of Alzheimer’s disease.Scientists discovered that blood ...